Quest Diagnostics Incorporated

NYSE:DGX

Sector

🏥 Health Care

Industries

💻 Telehealth

🩺 Medical Instruments

Location

United States

Market Cap

USD 20.03 B

Share Price

USD 179.43

Avg Daily Volume

1,324,738

Change (1 day)

-0.19%

Change (1 year)

29.83%

Change (YTD)

18.94%

Quest Diagnostics Incorporated Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2025: USD -28.00 M

Quest Diagnostics Incorporated Common Stock Issued is USD -28.00 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -159.57% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.

Quest Diagnostics Incorporated Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 47.00 M, a 88.00% change year over year.
Quest Diagnostics Incorporated Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 25.00 M, a -37.50% change year over year.
Quest Diagnostics Incorporated Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 40.00 M.
Quest Diagnostics Incorporated Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.00.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Common Stock Issued	Common Stock Repurchased	Free Cash Flow	Operating Cash Flow

NYSE: DGX

Quest Diagnostics Incorporated

CEO	Mr. James E. Davis
IPO Date	Dec. 17, 1996
Location	United States
Headquarters	500 Plaza Drive
Employees	55,000
Sector	🏥 Health Care
Industries Telehealth 🩺 Medical Instruments

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.